{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0008-0100#drug","name":"Besponsa","alternateName":"inotuzumab ozogamicin","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0008-0100"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"BLA761040"},{"@type":"PropertyValue","propertyID":"UNII","value":"P93RUU11P7"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"cc7014b1-c775-411d-b374-8113248b4077"}],"activeIngredient":"INOTUZUMAB OZOGAMICIN","administrationRoute":["INTRAVENOUS"],"dosageForm":"INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/BLA761040","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc7014b1-c775-411d-b374-8113248b4077","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0008-0100"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T22:16:25.279Z"}}